The stock of Model N, Inc. (NYSE:MODN) hit a new 52-week high and has $20.01 target or 7.00% above today’s $18.70 share price. The 8 months bullish chart indicates low risk for the $551.33 million company. The 1-year high was reported on Mar, 13 by Barchart.com. If the $20.01 price target is reached, the company will be worth $38.59M more. The stock decreased 0.53% or $0.1 during the last trading session, reaching $18.7. About 70,456 shares traded. Model N, Inc. (NYSE:MODN) has risen 18.66% since March 13, 2017 and is uptrending. It has outperformed by 1.96% the S&P500.
Oramed Pharmaceuticals Inc (NASDAQ:ORMP) had an increase of 30.34% in short interest. ORMP’s SI was 185,600 shares in March as released by FINRA. Its up 30.34% from 142,400 shares previously. With 54,000 avg volume, 3 days are for Oramed Pharmaceuticals Inc (NASDAQ:ORMP)’s short sellers to cover ORMP’s short positions. The SI to Oramed Pharmaceuticals Inc’s float is 1.73%. The stock increased 0.55% or $0.04 during the last trading session, reaching $7.32. About 11,569 shares traded. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has risen 2.79% since March 13, 2017 and is uptrending. It has underperformed by 13.91% the S&P500.
Investors sentiment decreased to 1.4 in 2017 Q3. Its down 0.22, from 1.62 in 2017Q2. It worsened, as 8 investors sold Model N, Inc. shares while 18 reduced holdings. 17 funds opened positions while 25 raised stakes. 16.24 million shares or 1.63% more from 15.98 million shares in 2017Q2 were reported. Northern Trust owns 263,302 shares. Jacobs Levy Equity Mgmt owns 15,580 shares. Rbf Cap Ltd Liability has invested 0.03% in Model N, Inc. (NYSE:MODN). Schwab Charles Inv holds 0% in Model N, Inc. (NYSE:MODN) or 45,800 shares. Deutsche State Bank Ag holds 0% in Model N, Inc. (NYSE:MODN) or 153,750 shares. Metropolitan Life Insur reported 16,742 shares. Redmile Grp Inc Lc accumulated 838,914 shares or 0.62% of the stock. Voya Investment Management Ltd Com reported 14,963 shares. Lyon Street Limited Liability Corporation holds 576,785 shares. Soros Fund Management Llc holds 0.77% or 2.16M shares in its portfolio. Morgan Stanley reported 169,367 shares. Ltd Liability invested in 0.02% or 47,799 shares. Golden Gate Private Equity owns 356,819 shares or 4.15% of their US portfolio. Lenox Wealth reported 104 shares. 4,356 are owned by Oppenheimer Asset Mgmt.
Analysts await Model N, Inc. (NYSE:MODN) to report earnings on May, 14. They expect $-0.18 earnings per share, up 47.06% or $0.16 from last year’s $-0.34 per share. After $-0.11 actual earnings per share reported by Model N, Inc. for the previous quarter, Wall Street now forecasts 63.64% negative EPS growth.
Among 9 analysts covering Model N Inc (NYSE:MODN), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Model N Inc had 11 analyst reports since February 16, 2016 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, November 16 report. The company was downgraded on Tuesday, December 12 by J.P. Morgan. The firm has “Hold” rating by Craig Hallum given on Tuesday, December 13. As per Tuesday, August 9, the company rating was downgraded by JMP Securities. On Tuesday, December 19 the stock rating was reinitiated by Dougherty & Company with “Buy”. JMP Securities upgraded the stock to “Buy” rating in Wednesday, February 7 report. The firm has “Buy” rating given on Tuesday, August 9 by Deutsche Bank. Craig Hallum initiated the stock with “Buy” rating in Tuesday, February 16 report. As per Friday, November 11, the company rating was upgraded by JP Morgan.
Model N, Inc. provides revenue management cloud solutions for the life science and technology industries. The company has market cap of $551.33 million. The firm develops applications, such as managed care and government pricing for life science companies; and channel incentives based on design wins for technology companies. It currently has negative earnings. It offers Revenue Enterprise Cloud, a set of transactional applications that serve as a system of record for, and automate the execution of revenue management processes, such as pricing, contracting, compliance, incentive, and rebate management.
Since February 15, 2018, it had 0 insider purchases, and 3 insider sales for $234,062 activity. 2,210 shares were sold by Anderson – Mark – Albert, worth $37,437 on Thursday, February 15. On Thursday, February 15 Gokhale Neeraj sold $27,578 worth of Model N, Inc. (NYSE:MODN) or 1,628 shares.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company has market cap of $105.20 million. The Company’s product portfolio includes ORMD-0801, an oral insulin capsule, which has completed Phase IIb clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which has completed Phase Ib clinical trials for the treatment of type 2 diabetes. It currently has negative earnings. The firm operates primarily in Israel.